Government Affairs
Refine Search
Pharmaceutical
The leading Australian trade group for the pharmaceutical industry has welcomed the delivery of a report into the medicines approval process in the country. 25 November 2021
Generics
The Russian government plans to conduct a pilot project in the domestic pharmaceutical sector that will involve conducting state procurements of drugs manufactured by companies that have a full-cycle production in one of the countries of the Eurasian Economic Union (EAEU). 23 November 2021
Biotechnology
British publicly-funded innovation catalyst The Cell and Gene Therapy Catapult (CGT Catapult) has reported strong growth in the country’s advanced therapy sector. 23 November 2021
Pharmaceutical
Ahead of the verdict of its medicines regulator, the US government has ordered 10 million doses of Pfizer’s investigational COVID-19 antiviral Paxlovid (ritonavir). 19 November 2021
Biotechnology
UK pharma major GlaxoSmithKline and US partner Vir Biotechnology announced US government contracts totaling around $1 billion to purchase sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19. 18 November 2021
Biotechnology
A set of guidelines that will provide a well-defined framework and guiding principle to facilitate sharing of biological information and data generated by research groups in India has been released by the government. 16 November 2021
Pharmaceutical
The European biopharmaceutical industry has signalled its support for a new Trade and Health Initiative, to be discussed by the World Trade Organization (WTO). 15 November 2021
Biotechnology
A row over who was responsible for developing the Spikevax COVID-19 vaccine has spilled out into the public domain. 12 November 2021
Biosimilars
Medicines for Europe, a trade group representing the generic and biosimilars sector in the region, has applauded efforts by the European Commission to improve the current intellectual property regime. 12 November 2021
Pharmaceutical
More than 90% of the approved identified rare diseases lack an approved treatment option. 10 November 2021
Pharmaceutical
Virginia-based pharma manufacturer Kaléo has agreed with the Department of Justice (DoJ) to pay $12.7 million to resolve allegations surrounding the submission of false claims for the drug Evzio, an injectable form of naloxone hydrochloride indicated for use to reverse opioid overdose. 10 November 2021
Pharmaceutical
US pharma giant Merck & Co and partner Ridgeback Biotherapeutics said yesterday the US government will exercise two of its options to purchase a total of 1.4 million additional courses of molnupiravir, an investigational oral antiviral for the treatment of COVID-19 patients. 10 November 2021
Biosimilars
Eager to create an ecosystem for innovation, a draft policy document prepared by India's Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers has proposed to cut down the time taken for regulatory approvals for innovative products by at least 50% within the next two years. The policy aims to catalyze R&D in the pharma and medtech sector, and to propel India to become a leader in drug discovery through incubating an entrepreneurial environment, reports The Pharma Letter’s India correspondent. 10 November 2021
Pharmaceutical
Spying a chance to remake the way innovative medicines are regulated in the UK, the British pharmaceutical industry is pressing the government to leverage the benefits of its newly-found independence from the European Union. 9 November 2021
Biotechnology
Further bad news for Emergent BioSolutions caused the US company’s share price to drop by 37% on Friday. 8 November 2021
Pharmaceutical
Campaigners were furious last week at the news that US President Joe Biden’s Build Back Better framework would exclude a plan permitting Medicare to use its bargaining power to lower the price of prescription drugs for Americans. 4 November 2021
Pharmaceutical
The Sustainable Markets Initiative (SMI), a network of global CEOs and private sector corporations targeting planet-friendly growth, has created a new task force focused on the healthcare sector. 4 November 2021
Pharmaceutical
Groups campaigning for lower US drug prices reacted with exasperation last week when President Joe Biden announced the framework for his Build Back Better Agenda and Bipartisan Infrastructure Bill. 1 November 2021
Pharmaceutical
pharma.be, the umbrella organization of 125 innovative pharmaceutical companies active in Belgium, regrets that the Constitutional Court has not taken an explicit decision to annul the discriminatory “clawback” measure in the pharmaceutical budget. 1 November 2021
Pharmaceutical
US President Joe Biden was never going to please everyone in announcing the framework for his Build Back Better Agenda and Bipartisan Infrastructure Bill, but the absence of provisions to lower drug prices is an issue that has caused particular anger among some Americans. 29 October 2021
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Pharmaceutical
Trade group the Association of the British Pharmaceutical Industry (ABPI) has had its say on UK government plans to overhaul the National Health Service (NHS). 21 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze